Emad Shash, Leading Cancer Researcher and Director at the National Cancer Institute, Cairo University, shared a post on LinkedIn:
“Yesterday at NCI BGO 2025 in Cairo, I had the pleasure of moderating “Beyond Dr. Google: Patient Education and AI in Oncology.”
Why this matters: Egypt’s digital reach is huge—and the infodemic is real. The session focused on AI’s impact on cancer patients and how to guide safe, smart use across the patient journey.
Key takeaways for patients, caregivers, and clinicians:
- Co-pilot, not autopilot: AI can explain labs, prep clinic questions, and support symptom tracking—but must never replace medical advice.
- Safety checklist: Seek source transparency, medical citations, date stamps, and clear limitations; avoid apps that hide data policies or push ads over evidence.
- Human-in-the-loop: Bring AI outputs to the visit; clinicians validate, contextualize, and document what’s used.
- Equity by design: Arabic-first, plain-language explainers and audio/visual options help narrow the digital divide.
- Governance and consent: Declare AI use, protect privacy, and rely on locally reviewed content with approval badges.
Our goal: turn AI from infodemic noise into a trusted ally that improves understanding, adherence, and shared decisions—without compromising safety or empathy.
Grateful to the team, partners, and our patients who keep us focused on what matters: clarity, trust, and outcomes.”
More posts featuring Emad Shash on OncoDaily.
